The Two Best Calls Ever on a Gold Bottom

Contributed Opinion
Source: Bob Moriarty  (04/28/2016)
Bob Moriarty of 321Gold calls out the work of two men who got it right on gold and silver. read more >

The Significance of Rising Commodities Prices…

Contributed Opinion
Source: Michael Ballanger  (04/27/2016)
The Significance of Rising Commodities Prices…
Precious metals expert Michael Ballanger expounds on how Federal Reserve policy affects the commodities markets, and expresses cautious optimism about how that policy will play out in gold markets. read more >

What Steve Jobs Knew About the Internet Can Make You a Better Gold Investor

Contributed Opinion
Source: Bob Moriarty  (04/27/2016)
What Steve Jobs Knew About the Internet Can Make You a Better Gold Investor
Of all the people in the tech world, Steve Jobs perhaps understood the potential of the Internet better than any of his peers. Bob Moriarty of 321Gold discusses how Jobs' insight can provide lessons on gold manipulation and what moves markets. read more >

Let Volatility Power Your Micro-Cap Biotechs

Source: George Mack of The Life Sciences Report  (04/27/2016)
Let Volatility Power Your Micro-Cap Biotechs
ROTH Capital Partners' Joseph Pantginis falls into that old-fashioned category of analysts who believe that good data can't help but drive a stock—no matter how far into the depths it may have sunk—and presents his detailed growth theory on two names, plus two picks for investors to do further diligence on. read more >
Management Q&A: View from the Top

Soligenix Fosters Potent Pipeline of Orphan Disease Compounds in Areas of Unmet Medical Need

Managment Q&A: View from the Top
Source: Special to The Life Sciences Report  (04/27/2016)
Soligenix Fosters Potent Pipeline of Orphan Disease Compounds in Areas of Unmet Medical Need
With a robust pipeline of drugs in late-stage clinical trials and milestones on the horizon, it's no wonder Soligenix Inc.'s CEO, Dr. Christopher Schaber, holds an optimistic view of the company's future. read more >

Are We or Are We Not in a New Gold Bull Market?

Contributed Opinion
Source: Jack Chan for The Gold Report  (04/26/2016)
Technical analyst Jack Chan has examined the charts and says that if we are in a new bull market, prices in both gold and gold equities should begin to pull back and consolidate soon. read more >

LiTHIUM X Is Not Alone—Profiling This Marketplace Darling and Others in the Sweet Spot

Source: Patrice Fusillo of The Gold Report  (04/25/2016)
LiTHIUM X Is Not Alone—Profiling This Marketplace Darling and Others in the Sweet Spot
After several years of bear markets for miners, many mining equities have lept upward in the last few months. LiTHIUM X Energy ranks among the leaders of the pack, up many-fold. Barry Allan, vice chair of mining at Mackie Research, and Research Analyst Ryan Hanley put out a report in March for the PDAC convention, highlighting a number of promising mining companies. In this interview they profile a handful of those companies, including LiTHIUM X. read more >
Expert Investing Ideas

"We are initiating coverage on DRRX with a Buy rating."

–Ram Selvaraju, Rodman & Renshaw


"We expect REGI to report healthy Q1/16 results."

–Craig Irwin, ROTH Capital Partners


"Significant potential remains in Europe for SNSS' Qinprezo."

–Maxim Jacobs, Edison Investment Research


Hold Reservoir Minerals After Takeout: Adrian Day

Contributed Opinion
Source: Adrian Day  (04/24/2016)
On Sunday, Reservoir Minerals announced it has agreed to be acquired by Nevsun Resources. Adrian Day shares his initial thoughts on the deal. read more >

Madness in the Crimex Trading Pits. . .

Contributed Opinion
Source: Michael Ballanger  (04/22/2016)
Madness in the Crimex Trading Pits. . .
Precious metals expert Michael Ballanger discusses effects of the Bank of Japan's actions on the U.S. dollar, silver and gold. read more >

President Trump? President Clinton? Gold Up in Both Scenarios

Source: Gordon Holmes of The Gold Report  (04/21/2016)
President Trump? President Clinton? Gold Up in Both Scenarios
Donald Trump and Hillary Clinton may have very little in common, but Barry Allan, vice chair of mining for Mackie Research Capital, says if either moves into the White House, the U.S. dollar will fall and gold will rise. A higher gold price bodes well for gold equities, and Allan and his colleague Ryan Hanley share the names of some of their top picks for this environment. read more >
Management Q&A: View from the Top

Relmada Therapeutics Launches Pharmaceutical Armada Against Chronic Pain and Opioid Abuse

Managment Q&A: View from the Top
Source: Special to The Life Sciences Report  (04/20/2016)
Relmada Therapeutics Launches Pharmaceutical Armada Against Chronic Pain and Opioid Abuse
To treat chronic pain without risk of addiction is to straddle a knife's edge. But Relmada Therapeutics Inc. has a small fleet of compounds in development that address both sides of an issue that has become a newsmaker, given the recent upsurge in heroin addiction and the ever-present conundrum of alleviating severe pain in chronic disease and after surgery. read more >